PHARMACEUTICAL CONTRACT MANUFACTURING
Day 2: 16th September 2026, London, United Kingdom
09:00 Comprehensive approaches to capacity planning and scalability challenges within contract manufacturing organizations and operational environments
This conference talk explores capacity planning and scalability challenges in contract manufacturing organizations. It highlights how demand variability necessitates flexible capacity and efficient resource allocation. The discussion addresses risks of over- and underutilization, emphasizing improved forecasting tools for better accuracy. It also covers modular facility investment, client collaboration on production alignment, and workforce planning to sustain scalable, efficient operations.
09:25 Questions & Discussion
PANEL DISCUSSION ON COLLABORATIVE PARTNERSHIPS
09:30 Risk Sharing and Partnership Models Between Pharmaceutical Companies and CMOs
This panel examines collaborative partnerships between pharmaceutical companies and CMOs, highlighting risk-sharing approaches and innovative engagement models. It covers performance-driven contracts, long-term collaborations, and governance structures that support accountability and operational stability. The discussion also underscores transparent communication, aligned financial risk, and strategic alliances that drive technology adoption, continuous improvement, and enhanced competitiveness across the global pharmaceutical value chain.
Discussion Topics:
09:30 How do structured partnership models enable allocation of risks and rewards between sponsors and CMOs?
09:40 Examine scope of performance-based contracts to align incentives and enforce mutual accountability.
09:50 Establishing Robust Communication Protocols and Governance Frameworks for Effective Strategic Partnerships
10:00 Financial risk-sharing models as catalysts for investment in emerging technologies and organizational capabilities
10:10 Role of Strategic Alliances in Strengthening Competitive Positioning within Pharmaceutical Contract Manufacturing Ecosystem
10:20 Interactive Discussion
11:00 Morning Break
PANEL DISCUSSION ON BIOLOGICS MANUFACTURING
11:30 Accelerating Resilient Biologics Manufacturing Through Strategic Outsourcing, Advanced Analytics, and Real-Time Monitoring
This session explores how biologics manufacturers and CDMOs are accelerating development, commercialization, and supply chain resilience through strategic outsourcing, integrated technology transfer, and advanced manufacturing platforms. It highlights the role of multi-site manufacturing, smart forecasting, Process Analytical Technology (PAT), and real-time analytics in improving operational efficiency, product quality, regulatory compliance, and supply continuity. Attendees will gain insights into building agile, data-driven biologics manufacturing networks capable of responding effectively to global disruptions and evolving market demands.
11:30 Accelerating Biologics Development and Commercialization Through Strategic CMO Partnerships
11:40 Scaling Commercial Biologics Production Using Integrated CDMO Technology Transfer and Automation Platforms
12:00 Strengthening Biologics CDMO Supply Chain Resilience Using Multi-Site Manufacturing and Smart Forecasting
12:10 Enhancing Biologics Supply Chain Continuity Amid Global Manufacturing Disruptions
12:20 Transforming Biologics Contract Manufacturing with Advanced PAT and Real-Time Monitoring
12:30 Smart Biologics Manufacturing: Leveraging Real-Time Analytics for Quality, Efficiency, and Compliance
12:40 Interactive Discussion
13:00 Lunch Break
PANEL DISCUSSION ON CONTINUOUS INNOVATION
14:00 Innovations in Continuous Manufacturing Within Pharmaceutical Contract Manufacturing
This panel explores how continuous manufacturing is reshaping pharmaceutical contract manufacturing organizations. Speakers examine gains in efficiency, consistency, and scalability over batch processing, alongside growing regulatory support. The discussion addresses required investments in technology and process redesign, the role of real-time monitoring in quality assurance, and the operational challenges of transitioning, highlighting how adopters secure competitive advantage for CMOs globally.
Discussion Topics:
14:00 Continuous manufacturing improves efficiency, consistency, and scalability compared to batch processes.
14:10 Regulatory agencies are increasingly supportive of continuous manufacturing adoption.
14:20 Implementation requires significant investment in technology and process redesign.
14:30 Real-time monitoring enhances quality control and reduces production variability.
14:40 Transitioning from batch to continuous systems presents operational challenges.
14:50 CMOs adopting continuous manufacturing gain competitive advantages in efficiency.
15:00 Interactive Discussion
15:30 Afternoon Break
PANEL DISCUSSION ON INNOVATION IN API MANUFACTURING
16:00 Leveraging Digitalization, Sustainability, and Faster Speed-to-Market to Transform Global Pharmaceutical Operations
Industry leaders will explore how digitalization, sustainability, and accelerated speed-to-market are reshaping pharmaceutical and API operations. Discussions will cover strategic pharma-CDMO partnerships, resilient supply chains, regulatory excellence, complex API scaling, and the evolving role of CMOs in supporting biotech and specialty pharma growth through innovation, agility, and operational excellence globally.
16:00 From Development to Commercialization: Strategic Partnerships Between Pharma and API CDMOs
16:10 Building Resilient API Supply Chains Through Advanced CMO Capabilities
16:20 Innovation in API Manufacturing: Digitalization, Sustainability, and Speed-to-Market
16:30 Navigating Regulatory Excellence in API CDMO Operations
16:40 Scaling Complex APIs: Challenges and Opportunities for Modern CDMOs
16:50 The Evolving Role of API CMOs in Supporting Biotech and Specialty Pharma Growth
17:00 Interactive Discussion
17:20 End of the Conference